A business in context

CELZ research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-24 · 0001477932-26-005811

  2. 8-K · Current report

    Report date 2026-09-24 · 0001477932-26-005805 · Items 1.01,3.02,9.01

  3. 8-K · Current report

    Report date 2026-08-28 · 0001477932-26-005329 · Items 5.03,5.07,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001477932-26-004779

  5. DEF 14A · Proxy statement

    Report date 2026-08-28 · 0001477932-26-004302

  6. 8-K · Current report

    Report date 2026-06-30 · 0001477932-26-004165 · Items 1.01,3.02,5.02,9.01

  7. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001477932-26-002893

  8. 10-K/A · Annual report

    Report date 2025-12-31 · 0001477932-26-002534

  9. 10-K · Annual report

    Report date 2025-12-31 · 0001477932-26-001517

  10. 8-K · Current report

    Report date 2025-12-26 · 0001477932-25-009277 · Items 5.07,9.01

  11. 8-K · Current report

    Report date 2025-12-18 · 0001477932-25-009094 · Items 5.07,9.01

  12. DEF 14A · Proxy statement

    Report date 2025-12-26 · 0001477932-25-008184

  13. 8-K · Current report

    Report date 2025-11-06 · 0001477932-25-008027 · Items 5.02,9.01

  14. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001477932-25-007978

  15. 8-K · Current report

    Report date 2025-10-29 · 0001477932-25-007849 · Items 1.01,3.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2025-10-27 · 0001477932-25-007803

  17. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001477932-25-005614

  18. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001477932-25-003498

  19. 8-K · Current report

    Report date 2025-05-05 · 0001477932-25-003370 · Items 5.07,9.01

  20. 10-K/A · Annual report

    Report date 2024-12-31 · 0001477932-25-002984

  21. 8-K · Current report

    Report date 2025-04-08 · 0001477932-25-002645 · Items 3.01,9.01

  22. 10-K/A · Annual report

    Report date 2024-12-31 · 0001477932-25-002473

  23. 10-K/A · Annual report

    Report date 2024-12-31 · 0001477932-25-001847

  24. DEF 14A · Proxy statement

    Report date 2025-03-19 · 0001477932-25-001759

  25. 8-K · Current report

    Report date 2025-03-10 · 0001477932-25-001737 · Items 5.02,9.01

  26. 10-K · Annual report

    Report date 2024-12-31 · 0001477932-25-001736

  27. 8-K · Current report

    Report date 2025-03-06 · 0001477932-25-001537 · Items 1.01,3.02,9.01

  28. 4 · Ownership change

    Report date 2025-02-18 · 0001477932-25-001159

  29. 8-K · Current report

    Report date 2024-12-19 · 0001477932-24-008314 · Items 5.03,5.07,9.01

  30. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001477932-24-006991

  31. DEF 14A · Proxy statement

    Report date 2024-12-19 · 0001477932-24-006871

  32. 8-K · Current report

    Report date 2024-10-22 · 0001477932-24-006644 · Items 1.01,9.01

  33. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001477932-24-004635

  34. 8-K · Current report

    Report date 2024-07-19 · 0001477932-24-004377 · Items 5.07,9.01

  35. 4 · Ownership change

    Report date 2023-06-27 · 0001477932-23-004914

  36. 4 · Ownership change

    Report date 2022-11-21 · 0001477932-22-008858

  37. 4 · Ownership change

    Report date 2022-09-27 · 0001477932-22-007311

  38. 4 · Ownership change

    Report date 2022-09-27 · 0001477932-22-007299

  39. 4 · Ownership change

    Report date 2022-09-21 · 0001477932-22-007108

  40. 4 · Ownership change

    Report date 2022-06-14 · 0001477932-22-004377

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 1 transaction rows1AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-24
2026-09-25
Creative Acquisition Corp.; Warbington TimothyA · Grant / award
Acquired
Common Stock1000000.0n/a

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001187953CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • JOLLEY MARKETING INC · former SEC name · 2002-09-13 to 2016-05-13

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$11.0K$11.8K
2023-12-31$9.0K$10.0K
2022-12-31$88.6K$102.0K
2021-12-31$87.8K$109.1K
2020-12-31$164.5K$214.2K
2019-12-31$165.5K$218.1K
2018-12-31$124.4K$166.9K
2017-12-31$4.8K$6.6K

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗